You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
The Canadian company said it will use the funding to support the US launch of its rapid, noninvasive test for platelet activation status.
OncoCell aims to enter the cancer prognostic space with its noninvasive immuno-genomics RNA transcriptomics prognostic platform to help differentiate patients with aggressive forms of prostate cancer from patients with indolent disease.
Designed for small and medium-sized labs, the system offers automated blood typing and screening based on gel card technology with minimum user intervention.
CEO Yoel Ezra said the firm plans to deploy a prototype in pilot studies next year, and is eyeing opportunities in the US, Europe, India, and the Middle East.
Magnolia has amended a complaint filed in a US District Court to allege that Kurin infringes four Magnolia patents.
The infusion set is designed to work with the company's Kurin Lock system for the prevention of blood collection contamination and false positives.
The Erytra Eflexis is a fully automated benchtop analyzer for pretransfusion compatibility testing that facilitates multiple lab configurations and features real random access.
Factors that may have led to the explosion in testing include more consultations between patients and general practitioners, and a fear among GPs of being sued.
The partners will use a $5M NCI grant to add seven biomarkers to an EGFR electrochemical assay for non-small-cell lung-carcinoma.
The instrument is a centrifuge/reader combo that automatically reads and transfers blood type and antibody screening results to patient data management software.